BIS icon

ProShares UltraShort NASDAQ Biotechnology
BIS

Overview Fund Trends Analyst Outlook Journalist POV

6 hedge funds and large institutions have $992K invested in ProShares UltraShort NASDAQ Biotechnology in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

85% less call options, than puts

Call options by funds: $4K | Put options by funds: $27K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4K
Puts
$27K
Net Calls
Net Calls Change

Top Buyers

1
+$45.8K
2
+$41.4K

Top Sellers

1
-$121K
2
-$24.2K
3
-$6K
4
Osaic Holdings
Osaic Holdings
Arizona
-$1.04K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$501K
2
$259K
3
$227K
4
$2.71K
5
$1.91K
6
$134
7
–
8
–